Evidence map›Paper›PMID 27489272›Full record

ArticleJournal of virology2016

ITCH E3 Ubiquitin Ligase Interacts with Ebola Virus VP40 To Regulate Budding.

Ziying Han, Cari A Sagum, Mark T Bedford, Sachdev S Sidhu, Marius Sudol, Ronald N Harty

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 69 citations in OpenAlex.

  1. The Pathology of Viral Infections.Advances in experimental medicine and biology · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. An evolutionarily conserved ubiquitin ligase drives infection and transmission of flaviviruses.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Chaperone-assisted selective autophagy targets filovirus VP40 as a client and restricts egress of virus particles.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Ziying HanDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Cari A SagumDepartment of Epigenetics and Molecular Carcinogenesis, M. D. Anderson Cancer Center, University of Texas, Smithville, Texas, USA.
Mark T BedfordDepartment of Epigenetics and Molecular Carcinogenesis, M. D. Anderson Cancer Center, University of Texas, Smithville, Texas, USA.
Sachdev S SidhuDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Marius SudolDepartment of Physiology, Institute for Molecular and Cell Biology (IMCB, AStar), National University of Singapore, Singapore.
Ronald N HartyDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA rharty@vet.upenn.edu.
The University of Texas MD Anderson Cancer Center · USUniversity of Pennsylvania · USNational University of Singapore · SGUniversity of Toronto · CA

Funding

Host-Oriented Therapeutics Targeting Filovirus Budding.R33AI102104 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HARTY, RONALD N · 2014 to 2016
$1.4M
Innate Immune Regulation of Intracellular Pathways Involved in Filovirus BuddingR21AI103785 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HARTY, RONALD N · 2014 to 2015
$440k
Host-Oriented Therapeutics Targeting Filovirus Budding.R21AI102104 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HARTY, RONALD N · 2012 to 2013
$423k
DEVELOPMENT OF SMALL MOLECULE THERAPEUTICS AGAINST RNA VIRUSESR41AI113952 · NIAID · FOX CHASE CHEMICAL DIVERSITY CENTER, INC · PI HARTY, RONALD N · 2015 to 2015
$300k
NIAID NIH HHS R21 AI102104NIAID NIH HHS R21 AI103785NIAID NIH HHS R33 AI102104NIAID NIH HHS R41 AI113952
6 · The paper itself

Abstract

unlabelledEbola virus (EBOV) and Marburg virus (MARV) belong to the Filoviridae family and can cause outbreaks of severe hemorrhagic fever, with high mortality rates in humans. The EBOV VP40 (eVP40) and MARV VP40 (mVP40) matrix proteins play a central role in virion assembly and egress, such that independent expression of VP40 leads to the production and egress of virus-like particles (VLPs) that accurately mimic the budding of infectious virus. Late (L) budding domains of eVP40 recruit host proteins (e.g., Tsg101, Nedd4, and Alix) that are important for efficient virus egress and spread. For example, the PPxY-type L domain of eVP40 and mVP40 recruits the host Nedd4 E3 ubiquitin ligase via its WW domains to facilitate budding. Here we sought to identify additional WW domain host interactors and demonstrate that the PPxY L domain motif of eVP40 interacts specifically with the WW domain of the host E3 ubiquitin ligase ITCH. ITCH, like Nedd4, is a member of the HECT class of E3 ubiquitin ligases, and the resultant physical and functional interaction with eVP40 facilitates VLP and virus budding. Identification of this novel eVP40 interactor highlights the functional interplay between cellular E3 ligases, ubiquitination, and regulation of VP40-mediated egress. IMPORTANCE: The unprecedented magnitude and scope of the recent 2014-2015 EBOV outbreak in West Africa and its emergence here in the United States and other countries underscore the critical need for a better understanding of the biology and pathogenesis of this emerging pathogen. We have identified a novel and functional EBOV VP40 interactor, ITCH, that regulates VP40-mediated egress. This virus-host interaction may represent a new target for our previously identified small-molecule inhibitors of virus egress.

Indexed as

Host-Pathogen InteractionsVirus ReleaseAnimalsCell LineEbolavirusHumansNucleoproteinsProtein Interaction MappingRepressor ProteinsUbiquitin-Protein LigasesViral Core ProteinsITCH protein, humanNucleoproteinsnucleoprotein VP40, Ebola virusRepressor ProteinsUbiquitin-Protein LigasesViral Core Proteins

Identifiers

PMID27489272
PMCPMC5044852
OpenAlexW2493713544

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.